poisar

Stocks · News reference

Citigroup Maintains Neutral on Icon, Raises Price Target to $180

BenzingaJul 31, 2026, 8:13 PMBenzinga Newsdesk

Citigroup analyst Brendan Digan maintains Icon (NASDAQ:ICLR) with a Neutral and raises the price target from $165 to $180.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 31, 2026, 8:13 PM
Checked
Jul 31, 2026, 8:13 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncAug 5, 2026, 4:30 AMHealthcare Foresights

    [Latest] Global eClinical Solutions Market Size/Share Worth USD 42.55 Billion by 2035 at a 13.98% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

    The global eClinical Solutions market is projected to grow from USD 11.50 billion in 2025 to USD 42.55 billion by 2035, at a CAGR of 13.98%. Growth is driven by increased demand for efficient clinical trials, rising chronic disease prevalence, adoption of AI and cloud computing technologies, and decentralized trial models. Key players include Oracle, Veeva Systems, IQVIA, Medidata Solutions, and IBM Watson Health.

    Read original at globenewswire-inc